A Comperative Study Of Dexmedetomedine And Sevoflurane In Laproscopic Cholecystectomy Observing Haemodyanamic Parameters

Comparison Of Efficacy Of Dexmedetomedine And Sevoflurane On Haemodynamic Parameters In Patients Undergoing Laparoscopic Cholecystectomy - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036420

Enrollment

Registered

2021-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dexmedetomedine: Dexmedetomedine is an alpha2 agonist, given @.5mcg/kg/min for first 10 minutes, then 0.5mcg/kg/hrs infusion dose, stopped at the removal of tracer. Control Interventi

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASa grade 1 and ASA grade 2 Patients scheduled for elective laparoscopic cholecystectomy under general anaessthesia With endotracheal intubation

Exclusion criteria

Exclusion criteria: Unwilling patients. Patients with anticipated difficult intubation. Patients with labeled blood pressure, severe renal, endocrine and cardiac dysfunction, heart block. Patients on Beta-blocker drugs. Patients with asthma, chronic obstructive lung disease, Cystic fibrosis. Morbidly Obese patients. Patients with history of alcohol/drug abuse. Pregnant and lactating patients.

Design outcomes

Primary

Measure	Time frame
Hemodyanamic Parameters (Heart Rate, SBP, DBP, MAP, ETCO2, Respiratory Rate, SpO2)Timepoint: From before induction at 5 mins interval upto after extubation	—

Secondary

Measure	Time frame
NilTimepoint: NA	—

Countries

India

Contacts

Public ContactAnamitra Poddar

Bankura Sammilani Medical College

anamitrapoddar9@gmail.com9674892720

Outcome results